Ceftazidime-related nonconvulsive status epilepticus

A. D. Klion, J. Kallsen, C. T. Cowl, W. M. Nauseef

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


The third-generation cephalosporin, ceftazidime, is widely used for the treatment of serious gram-negative infections. As is true of cephalosporins in general, reported adverse effects have been few. We report a case of ceftazidime-induced status epilepticus in a patient with Pseudomonas aeruginosa meningitis and compare the clinical manifestations of this case with those of two previously described cases of ceftazidime-related encephalopathy. This diagnosis should be entertained and an electroencephalogram should be obtained in all patients with myoclonus and/or altered mental status while they are receiving ceftazidime therapy.

Original languageEnglish (US)
Pages (from-to)586-589
Number of pages4
JournalArchives of internal medicine
Issue number5
StatePublished - 1994

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Ceftazidime-related nonconvulsive status epilepticus'. Together they form a unique fingerprint.

Cite this